You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Twitter Demographics
Mendeley readers
Attention Score in Context
| Title |
Liposomal extended-release bupivacaine for postsurgical analgesia
|
|---|---|
| Published in |
Patient preference and adherence, September 2013
|
| DOI | 10.2147/ppa.s32175 |
| Pubmed ID | |
| Authors |
Zongbing You, Lambrechts, Michael O'Brien, Savoie |
| Abstract |
When physicians consider which analgesia to use postsurgery, the primary goal is to relieve pain with minimal adverse side effects. Bupivacaine, a commonly used analgesic, has been formulated into an aqueous suspension of multivesicular liposomes that provide long-lasting analgesia for up to 72 hours, while avoiding the adverse side effects of opioids. The increased efficacy of liposomal extended-release bupivacaine, compared to bupivacaine hydrochloride, has promoted its usage in a variety of surgeries including hemorrhoidectomy, bunionectomy, inguinal hernia repair, total knee arthroplasty, and augmentation mammoplasty. However, like other bupivacaine formulations, the liposomal extended-release bupivacaine does have some side effects. In this brief review, we provide an update of the current knowledge in the use of bupivacaine for postsurgical analgesia. |
Twitter Demographics
The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| Russia | 1 | 1% |
| France | 1 | 1% |
| Romania | 1 | 1% |
| Unknown | 81 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 17 | 20% |
| Student > Postgraduate | 10 | 12% |
| Other | 9 | 10% |
| Student > Master | 7 | 8% |
| Student > Doctoral Student | 7 | 8% |
| Other | 25 | 29% |
| Unknown | 11 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 42% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 7% |
| Unspecified | 5 | 6% |
| Agricultural and Biological Sciences | 5 | 6% |
| Nursing and Health Professions | 4 | 5% |
| Other | 11 | 13% |
| Unknown | 19 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2019.
All research outputs
#6,766,904
of 22,719,618 outputs
Outputs from Patient preference and adherence
#448
of 1,588 outputs
Outputs of similar age
#59,085
of 200,186 outputs
Outputs of similar age from Patient preference and adherence
#9
of 40 outputs
Altmetric has tracked 22,719,618 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,588 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,186 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.